摘要
目的探讨尿β2微球蛋白(β2-MG)和血超敏C反应蛋白(HS-CRP)联合检测对糖尿病早期肾损伤的应用价值。方法用全自动生化分析仪测定89例2型糖尿病患者和50例健康人的血超敏C反应蛋白和尿β2微球蛋白含量。结果糖尿病组β2-MG和HS-CRP明显高于健康人组(P<0.01),且联合检测阳性率达89.9%,明显高于单项检测。结论尿β2-MG与血HS-CRP是糖尿病早期肾损伤的敏感指标,联合检测更为敏感。
Objective To study the clinical value of determination of urinary β2microglobulin (β2-MG) and hypersensitive C reaction protein (HS-CRP) in diagnosis of early stage diabetic nephropathy. Methods β2-MG and HS-CRP in 89 patients with type Ⅱ diabetes and 50 healthy subjects were measured by automatic biochemical analyzer. Results Compared with healthy control group, the urinary β2-MG and HS-CRP in diabetic nephropathy group were significantly higher (P 〈 0.01), and the positive rate in determination of β2-MG and HS-CRP combined together was significantly higher (89.9 %) than either one. Condusion The level of β2-MG and HS-CRP are sensitive parameters in early stage of diabetic nepropathy especially in combined determination of both levels.
出处
《生物医学工程与临床》
CAS
2006年第5期313-314,共2页
Biomedical Engineering and Clinical Medicine
关键词
Β2微球蛋白
超敏C反应蛋白
糖尿病肾病
β2 miciroglobulin (β2-MG)
hypersensitive C reaction protein (HS-CRP)
diabetic nephropathy